Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 14 January 2026

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin stock rises after missile flight test as Pentagon motor deal keeps defense names in focus

Lockheed Martin shares rose 2.3% to $571.40 Wednesday after the company announced its first flight test of the Next-Generation Short-Range Interceptor at White Sands. The gains outpaced the S&P 500, which fell 0.8%. Investors responded to new Pentagon efforts to secure the missile supply chain, including a $1 billion investment in L3Harris Technologies’ rocket-motor division.
14 January 2026
····
Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

Trip.com stock sinks nearly 18% after China antitrust probe notice — what investors watch now

Trip.com’s U.S.-listed shares plunged 17.7% to $62.26 after China’s market regulator opened an antitrust investigation into the company. The State Administration for Market Regulation is probing suspected abuse of market dominance but has not detailed the allegations. Trip.com said operations continue as normal and pledged cooperation. Hong Kong shares fell 6.5% earlier in the day.
14 January 2026
···
Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Praxis Precision Medicines (PRAX) stock jumps after Devinsky hire as FDA filings loom

Shares of Praxis Precision Medicines rose about 8% to $303.23 by mid-afternoon Wednesday after the company named epilepsy specialist Dr. Orrin Devinsky as head of clinical strategy. Investors are watching two FDA drug applications set for mid-February. Praxis recently raised $575 million in a public offering. The broader biotech sector outperformed the market, while major indexes fell.
14 January 2026
·
Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer shares rose 2% to $25.65 Wednesday after CEO Albert Bourla said the company is “all in on obesity” and plans 10 Phase 3 trials for its Metsera compounds by 2026. Pfizer does not expect revenue growth to return until 2029 as it faces patent expirations and weaker COVID-related sales. AbbVie also announced new obesity drug plans. Novo Nordisk warned of tougher competition in 2026.
14 January 2026
···
MP Materials stock pops as William Blair starts coverage and rare-earth price floors hit the agenda again

MP Materials stock pops as William Blair starts coverage and rare-earth price floors hit the agenda again

Shares of MP Materials surged 7.5% Wednesday, closing at $68.63 after swinging between $62.20 and $68.73. The move followed William Blair’s new coverage and G7 talks on rare-earth price floors. MP’s recent filings show a $400 million Pentagon deal with a 10-year price floor for neodymium-praseodymium. Apple signed a $500 million rare-earth magnet contract with MP last year.
14 January 2026
·
1 … 558 559 560 561 562 … 1,946

Stock Market Today

Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

7 February 2026
Sao Paulo, February 7, 2026, 08:51 (BRT) — Market closed Banco Bradesco S.A.’s preferred shares (BBDC4) closed on Friday down 2.55% at 20.61 reais, after swinging between 19.83 and 20.70 reais on the day. Turnover was about 94.1 million shares, leaving the stock sitting with fresh guidance to digest before trading resumes on Monday. (Investing.com Brasil) The move came against a firmer backdrop. Brazil’s Ibovespa ended Friday up 0.45%, notching its fifth straight weekly gain as foreign inflows kept the benchmark supported even as some investors stayed wary of the next macro turns. (InfoMoney) A regulatory filing showed Bradesco’s recurring
Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026
Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.
Intel stock jumps on China server CPU delays as traders map the week ahead

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026
Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.
IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026
IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.
Go toTop